Proqr therapeutics i inc
WebbFör 1 dag sedan · Find the latest Price To Free Cash Flow for ProQR Therapeutics (PRQR) Skip to main content. We use cookies to understand how you use our site and to ... Webb14 apr. 2024 · ProQR Therapeutics has a 12 month low of $0.53 and a 12 month high of $3.85. The firm has a market capitalization of $183.46 million, a price-to-earnings ratio …
Proqr therapeutics i inc
Did you know?
Webb6 apr. 2024 · ProQR Therapeutics - PRQR News Today $2.23 +0.01 (+0.45%) (As of 04/6/2024 12:00 AM ET) Compare Today's Range $2.13 $2.27 50-Day Range $1.99 $3.66 52-Week Range $0.53 $3.85 Volume 612,712 shs Average Volume 1.67 million shs Market Capitalization $180.23 million P/E Ratio N/A Dividend Yield N/A Price Target $4.50 … WebbFör 1 dag sedan · ProQR Therapeutics N.V. (PRQR) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 2.2300 +0.0100 (+0.45%) At close: 04:00PM EDT 2.2400 +0.01 (+0.45%) After hours: 07:12PM EDT...
Webb29 mars 2024 · ProQR Therapeutics N.V. rapporteerde winstresultaten voor het volledige jaar eindigend op 31 december 2024. Voor het volledige jaar rapporteerde het bedrijf een omzet van EUR 4,04 miljoen, vergeleken... 14 april 2024 Webb14 mars 2024 · LEIDEN, Netherlands & CAMBRIDGE, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it has successfully defended against two oppositions that were filed against a key patent for its ADAR …
WebbProQR Therapeutics NV The University of Manchester Company Website About Specialising in strategic business relationships, incorporating business development over a 20 year+ career in...
Webb10 apr. 2024 · WAVE LIFE SCIENCES LTD (2024) WVE. The BPs are making there moves into the RNA modality. Wave Life Sciences has picked up another deal with a major pharma company. The Massachusetts-based biotech ...
WebbProQR Therapeutics的新闻 ProQR(PRQR.US)盘前涨超12% 宣布与礼来进行Aximer RNA编辑许可和研究合作. ProQR Therapeutics(PRQR.US)盘前涨超12%报7.65美元。此前该公司宣布与礼来公司进行Aximer RNA编辑许可和研究合作，共同开发针对多达5个靶点的编辑寡核苷 … ottava di sant\\u0027agataWebbDas durchschnittliche ProQR Therapeutics N.V. Kursziel beträgt 4,36 $. Das ist 95,34 % höher als der aktuelle Aktienkurs. Das höchste Kursziel liegt bei 6,06 $ 171,76 %, das … ottava di sant\\u0027egidioWebbProQR Therapeutics N.V., or “ProQR” or the “Company”, is a development stage company domiciled in the Netherlands that primarily focuses on the development and commercialization of novel therapeutic medicines. Since September 18, 2014, the Company’s ordinary shares are listed on the NASDAQ Global Market under ticker symbol … ottava di sant\u0027agataWebb23 dec. 2024 · PROQR THERAPEUTICS NV WKN: A12B97 ISIN: NL0010872495 Ticker-Symbol: 0PQ Tradegate 24.03.23 20:28 Uhr 3,175 Euro -0,014 -0,44 % Nachrichten Analysen Kurse Chart Branche Biotechnologie... ottava detroitWebbPROQR THERAPEUTICS I B.V. – Org.nummer: 502087-7824. På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m. ottava definizioneWebb14 apr. 2024 · Several equities analysts have issued reports on PRQR shares. Citigroup cut their price target on shares of ProQR Therapeutics from $3.00 to $2.25 in a report on Friday, April 7th. HC Wainwright increased their target price on shares of ProQR Therapeutics from $1.50 to $5.00 and gave the company a "buy" rating in a research … イオン jmbカードとはWebbProQR Therapeutics 9 553 följare på LinkedIn. Advancing our proprietary Axiomer RNA-editing platform technology Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary Axiomer RNA … イオン jtb 営業時間